Onco-Innovations Limited
ONCO
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 254.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 254.93% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | 254.93% | |||
| SG&A Expenses | -26.13% | 403.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.72% | 291.25% | |||
| Operating Income | 25.11% | -292.15% | |||
| Income Before Tax | 14.00% | -34.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.00% | -34.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.00% | -34.84% | |||
| EBIT | 25.11% | -292.15% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 17.33% | -30.16% | |||
| Normalized Basic EPS | 17.06% | -30.00% | |||
| EPS Diluted | 17.33% | -30.16% | |||
| Normalized Diluted EPS | 17.06% | -30.00% | |||
| Average Basic Shares Outstanding | 3.98% | 3.48% | |||
| Average Diluted Shares Outstanding | 3.98% | 3.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||